Skip to content

Search

Search managers or tickers

ValueAct Capital

Q4 2017 13F · by Mason Morfit, CIO

As of
Dec 31, 2017
Filed
Feb 14, 2018
US stock
$9.9B · prev $10.0B
Positions
13 · prev 14
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves10 since the prior filing

The book

Very concentrated · behaves like 9 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Low turnover · 11% a year, about 9.1 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions64% of US stock

  1. unresolved Twenty First Centy Fox Inc held held18.4%
  2. BFH Bread Financial Holdings, Inc. held held15.1%
  3. CBRE Cbre Group, Inc. trimmed−0.04 pp trimmed−0.0410.9%
  4. unresolved Kkr & Co L P DEL added+0.90 pp added+0.9010.2%
  5. MS Morgan Stanley added+0.90 pp added+0.909.5%

Positions13 in this filing · 3 exited

unresolvedTwenty First Centy Fox Inc18.41%53,326,334$1.8Bheld—15 q
BFHBread Financial Holdings, Inc.15.07%5,877,400$1.5Bheld—8 q
CBRECbre Group, Inc.10.92%24,916,923$1.1Btrimmed−14%−0.04 pp19 q
unresolvedKkr & Co L P DEL10.18%47,750,000$1.0Badded+5%+0.90 pp3 q
MSMorgan Stanley9.53%17,959,620$942Madded0%+0.90 pp7 q
STXNSeagate Technology Holdings PLC (Ireland)9.08%21,458,600$898Mheld—7 q
MSFTMicrosoft Corp7.80%9,014,063$771Madded0%+1.07 pp19 q
TRNTrinity Industries, Inc.7.05%18,607,352$697Madded+8%+1.53 pp7 q
AWIArmstrong World Industries, Inc.5.64%9,202,612$557Mheld—15 q
unresolvedValeant Pharmaceuticals Intl3.79%18,010,027$374Mheld—19 q
unresolvedExpress Scripts Hldg Co0.91%1,200,000$90Mnew+0.91 ppnew
CCitigroup Inc.0.83%1,100,000$82Mnew+0.83 ppnew
AFIIQArmstrong Flooring Inc0.79%4,609,071$78Mheld—7 q
BKRBaker Hughes Company—−31,407,820—exited−11.53 pp—
WTWWillis Towers Watson Public Limited Company—−2,980,008—exited−4.61 pp—
BIVVBioverativ Inc—−1,270,619—exited−0.73 pp—

Source

Form
13F-HR
Reading
0 defects · 4 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet